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Abstract 
Introduction: Fluoroscopy integration with three dimensional (3D) electroanatomical 
mapping system may allow dose reduction while invasive electrophysiological procedures. In 
this retrospective study we present real-population experience with integrated model.   
Material and methods: 96 patients with paroxysmal AF after radiofrequency (RF) 
pulmonary vein isolation (PVI) have been analyzed. In 48 patients, 3D mapping system 
integrated with fluoroscopy (Carto 3 UniVu) has been used. Clinical and peri-procedural data, 
inclusive, fluoroscopy time and dose, in-hospital complications and efficacy rate at 6 months 
have been compared.  
Results: Patients treated with classic 3D mapping system were significantly older (p = 0.036). 
Both fluoroscopy mean time (11.6 ± 4.3 vs. 6.7 ± 2.9 minutes, p <0.05) and a median of the 
fluoroscopy dose (460.0 [IQR: 288.0; 785.5] vs. 271.0 [IQR: 145.0; 535.0] mGy, p <0.05) 
have been significantly reduced by using Carto3 UniVu. Total procedure time was comparable 
between groups. Periprocedural complications and recurrence of clinical arrhythmia rate in 6-
month follow-up were comparable.  
Conclusions: Utilization of novel 3D mapping systems with classic fluoroscopy integration 
support the radiation time and the dose reduction during AF ablation procedure, without any 
adverse impact on the total procedure time neither complication or success rate. This real-life 
population results corresponds with previously presented prospective studies. 
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Streszczenie 
Wstęp: Integracja obrazu fluoroskopowego z systemem obrazowania elektroanatomicznego 
3D może zmniejszać ekspozycję na promieniowanie jonizujące podczas zabiegów 
elektrofizjologicznych. W tym retrospektywnym badaniu prezentujemy wyniki stosowania 
zintegrowanego systemu elektroanatomicznego u pacjentów poddawanych ablacji migotania 
przedsionków w codziennej praktyce. 
Materiał i metody: Przeanalizowano 96 pacjentów z napadowym migotaniem przedsionków 
poddanych zabiegowi izolacji żył płucnych prądem o częstotliwości radiowej. U 48 z nich 
wykorzystano system elektroanatomiczny 3D zintegrowany z fluoroskopią (Carto 3 UniVu). 
U pozostałych zastosowano klasyczny system elektroanatomiczny 3D (Carto 3). Analizie 
poddano dane kliniczne a także około zabiegowe, szczególnie dawkę i czas skopi, a także 
częstość powikłań i nawrotu arytmii w okresie 6 miesięcy. 
Wyniki: Pacjenci leczeni z użyciem klasycznego system 3D byli istotnie starsi (p = 0,036). 
We wszystkich przypadkach uzyskano całkowitą izolację żył płucnych. Zarówno średni czas 
skopi (11,6 ± 4,3 vs. 6,7±2,9 minut, p <0,05) jak i mediana dawki (460,0 [IQR: 288,0; 785,5] 
vs. 271,0 [IQR: 145,0; 535,0] mGy, p < 0,05) były istotnie mniejsze u pacjentów w grupie 
Carto3 UniVu. Całkowity czas zabiegu był w obydwu grupach porównywalny. Częstość 
powikłań około zabiegowych oraz nawrotu klinicznej arytmii była porównywalna w obydwu 
grupach.  
Wnioski: Wykorzystanie nowego systemu elektroanatomicznego 3D zintegrowanego z 
klasyczną fluoroskopią pozwala na zmniejszenie ekspozycji na promieniowanie jonizujące 
podczas zabiegów ablacji migotania przedsionków nie wpływając jednocześnie negatywnie 
na czasu zabiegu ryzyko komplikacji czy skuteczność. Dane te, uzyskane w toku codziennej 
praktyki, korespondują z wcześniejszymi dowodami uzyskanymi z badań klinicznych.   




The ablation of atrial fibrillation (AF) with the usage of the radiofrequency energy (RF) is a 
well-established and widely performed procedure in electrophysiology (EP) laboratories [1]. 
However, high radiation doses during a single procedure, a repetitive exposure of the 
electrophysiology lab personnel as well as possible genetic consequences [2] gave rise to the 
persistent search for the new ways of radiation exposure reduction.  
Implementation of electroanatomical systems in a daily clinical practice has 
significantly reduced the applied doses in a single procedure [1,3,4]. The current studies 
focusing on the complex left atrial ablation undermine the necessity of X-ray radiation in such 
procedures [5]. Therefore, the further investigation to optimize the navigation and to reduce 
the radiation exposure are needed. One of the possible ways is the integration of classical 
fluoroscopy and the 3D model created with electroanatomical system [6,7].  
This work is aimed to demonstrate the clinical experience in radiofrequency ablation 
of atrial fibrillation using the integrated module in real-life population. 
 
Material and methods: 
Study objectives  
To show the possible improvement in efficacy, safety and fluoroscopy time reduction during 
AF ablation with integrated mapping module (Carto 3 UniVu™), the clinical, peri-procedure 
data, in-hospital complications and efficacy at 6th month after the ablation with classic 3D 
mapping system have been compared.  
Technology description 
UniVu™ is the Carto 3 module, that allows integrating entirely the classic fluoroscopy image 
with electroanatomical maps (EAM). In order to obtain an integrated image, two additional 
components are needed: a registration plate — mounted on the location pad — and the 
software component. A complete localizing calibration during each consecutive procedure — 
‘registration’ — is achieved through the capture of the disc marker located on the Registration 
plate. After the “registration”, prerecorded single x-ray images, fluoroscopy video loops or 
left atrium (LA) angiographies could be transferred to mapping system and combined with 
EAM. Such approach allows to project the catheters on those images in real-time and repeated 
utilization of fluoroscopy is not necessary. Two different views can be used simultaneously. 
Other technical details of this module have previously been described [6,7]. 
 
Population  
The population study consists of 96 patients with the symptomatic, documented, drug-
resistant paroxysmal AF, who have undergone pulmonary vein isolation between May 2014 
and May 2015. The patients were included into analysis, if were > 18 years old. The exclusion 
criteria were: prior AF ablations, significant enlargement of left atrium in transthoracic 
echocardiography (TTE) — defined as LA > 55mm in TTE long axis view — or the need for 
LA substrate modification with the additional ablations lines.  
 
Pre-ablation procedure  
Prior to the admission the computer tomography (CT) for 3D cardiac imaging was performed. 
On admission to hospital all patients underwent clinical examination, laboratory check and 
transesophageal echocardiography (TEE) for the recognition of the intra-cardiac thrombi. If 
thrombus was found, the patient was not qualified to the procedure, and the ablation was 
postponed. Medication with vitamin K antagonists (VKA) and novel anticoagulant drugs 
(NOAC) was interrupted one day prior admission and withdraw during hospitalization. In 
patient with INR < 2,0 or in patients on NOAC, the additional low molecular weight heparin 
(LMWH) was administered.  
Anti-arrhythmic medication was continued during the hospital stay and modified if needed.  
Catheter Ablation Procedure  
All procedures were performed by two experienced operators (more than 5 years of 
experience in EP studies and AF ablations). The procedures were performed, after written 
informed consent, under general anesthesia using sevoflurane and/or Propofol with boluses of 
midazolam and fentanyl. During the whole procedure time the patients stayed under 
anesthetist control. For invasive blood pressure monitoring, routinely radial approach was 
used. The intraesophageal temperature feedback during the ablation was achieved by the 
usage of a temperature probe (SensiTherm, St Jude Medical). After veins punctures, decapolar 
steerable coronary sinus catheter and quadric-polar non-steerable right ventricular apex 
catheter were placed under fluoroscopy guidance. A single transseptal puncture (TSP) was 
performed directly with the use of steerable sheath — Agilis, St Jude Medical, St Paul, MN). 
After TSP, heparin was administrated and added to achieve ACT level of 300-350 seconds. In 
the case of AF ablation with UniVuTM Module after positioning of the diagnostic catheters and 
fluoroscopy guided TSP, localizations reference for UniVuTM Module were registered. 
Thereafter, routinely right anterior oblique (RAO), left anterior oblique (LAO) and posterior-
anterior (PA) cine loops were captured (Figure 1). The electroanatomical map of LA was 
created and merged with reconstructed CT scans. In patients ablated with UniVuTM Module 
obtained additional fluoroscopy information (cine loops) were used to facilitate the CT - 
merging. For LA mapping and ablation, pre-recorded cine loops were used predominantly. 
The level of temperature probe in the esophagus in reference to ablation catheter was 
controlled using fluoroscopy. All mapping and RF ablation were performed with the same 
ablations catheter: F or D-Type, irrigated tip, Thermocool® SmartTouchTM Catheter 
(Biosence Webster, Inc., Diamond Bar, CA) which allowed for the measurements of catheter 
contact force. For ablation, a maximum power of 35 Watts, upper temperature limit of 43oC 
and flow rate of 30ml/min were set. Maximal power delivered at posterior wall and near 
esophagus was reduced and adapted according to the intraesophageal temperature. To avoid 
the atrio-esophageal fistula, intraesophageal temperature was limited to 41oC [8]. In all cases, 
the circumferential ablation around the pulmonary veins (PV) was performed. The acute 
success of the procedure was defined as the bidirectional conduction block for PV isolations 
lesions after 20 minutes from the last application proven by both: pacing along ablation line 
with mapping catheter (MAP), thereafter with a multipolar spiral mapping catheter (Lasso® 
eco NAV catheter, Biosense Webster) introduced via Agillis after MAP removal. After 
ablation and removal of the Agilis sheath from LA, protamine was administered to the reverse 
heparin. If the activated clot time was lower than 200 seconds, the femoral sheaths were 
removed. LMWH was continued 6 hours after the procedure — after exclusion of groin 
complications and pericardial effusion in TTE. We recommend continuing previous 
anticoagulation therapy after the procedure. 
Between May and November 2014 only the Carto 3 electroanatomical mapping 
system was used (Carto 3 group). UniVuTM Module was not available. Thereafter, during 
consecutive 6 months, we performed AF ablations only with Carto UniVuTM support (UniVu 
group). 
 
Analyzed parameters  
Demographics data and body mass measurements were collected on the day of admission. For 
the calculation of the stroke risk and bleeding risk, CHA2DS2-VASc score and HASBLED 
score were used. LA diameter was measured in a TTE parasternal long-axis view and the LA 
area was measured in an apical four-chamber view. The total procedure time was measured 
from the first femoral puncture to the removal of all sheaths. All patients have been controlled 
and undergone 7-days Holter electrocardiogram monitoring in our outpatient clinic after 3 and 
6 months form hospital discharge.  
Statistical analysis  
Continuous parameters with normal distribution were presented as an arithmetic mean ± 
standard deviation, while qualitative parameters were presented as percentages. The 
parameters the distribution of which was found to be different than normal were presented as 
a median with an interquartile range (IQR). The differences regarding clinical and 
periprocedural parameters were compared with t-Student, λ2 test or U-Mann Whitney 
respectively. Statistical significance was considered by p≤ 0.05 bilateral. All analyses were 
conducted using Statistica 10.0. 
 
Results 
Study population, efficacy and safety endpoints  
We analyzed 96 patients with paroxysmal atrial fibrillation, who have undergone PV isolation 
with 3D electroanatomical mapping system. We included 48 consecutive patients both in 
Carto 3 group and UniVu group. Patients treated with the support of UniVuTM Module were 
younger (p = 0.036). No further statistical differences in demographic and echocardiographic 
data were observed (Table I). Furthermore, neither total procedure time (140 ± 27 vs. 149 ± 
24 minutes, p = ns) nor the acute success rate (100% vs. 100%, p = 1.0) were significantly 
different. The rate of complications and in-hospital AF episodes after the ablation were 
comparable in both groups. During the hospital stay there were noted complications such as: 
two haematomas and one femoral bleeding that needed blood transfusion. After 6 months 
follow-up 78.2% of the patients of the whole study population were free from arrhythmia. 
There were no statistically significant differences between two compared groups. (Table II). 
 
Fluoroscopy  
In the UniVu group, a significant reduction in the mean total fluoroscopy time (11.6 ± 4.3 vs. 
6.7 ± 2.9 minutes, p<0.05) was observed. The decrease corresponded to a reduction of the 
median total fluoroscopy dose (460.0 [IQR: 288.0; 785.5] vs. 271.0 [IQR: 145.0; 535.0] mGy, 
p < 0.05). The results of the radiation exposure are presented in the Table II. 
 
Learning curve  
Out of 48 patients ablated with an integrated module, a radiation exposure data of the first 10 
patients and the next 38 patients were compared. The growing operators’ work experience 
with the integrated module allowed a significant reduction in the total fluoroscopy time (8.3 ± 
3.0 vs. 6.3 ± 2.8 minutes, p = 0,044).  
 
Discussion 
In our study we found that the usage of an integrated model of classic fluoroscopy and 3D 
mapping system is a feasible and effective technology for the interventional AF ablation. The 
usage of it shows the same acute success rate in the same procedure time with a lower use of 
the total fluoroscopic time and dose. These results correspond with data obtained from 
prospective studies [6,7]. 
The usage of 3D mapping systems as a clinical routine in an interventional 
electrophysiology was correlated with the reduction of the total fluoroscopy time and dose. 
Estner et al. in a prospective randomized study demonstrated a significant reduction in the 
total fluoroscopy exposure time (p < 0.01) and dose (p = 0.03) in patients who underwent 
catheter ablation for drug refractory AF using 3D system [9]. The same group from Italy [10] 
compared clinical data of patients with atrial fibrillation who had undergone circumferential 
PV isolation with use of 3D Carto 3 or Carto XP system. The acute success rate was the same 
in both groups. In the same time of the procedure duration (157 ± 67 vs. 159 ± 65 minutes, p 
= 0.8), the use of Carto 3 system was associated with the reduction in fluoroscopy time (15.9 
± 12.3 vs. 26.0 ± 15.1 minutes, p<0.001). The reduction of fluoroscopy time in Carto 3 group 
was greater in patients with paroxysmal AF (14.2 ± 12.7 vs. 26.3 ± 15.2 minutes, p < 0.001). 
Our results are comparable with data form prospective studies analyzing results of 
utilization Carto 3 with UniVuTM Module during AF ablation [6,7,11]. The use of fluoroscopy 
integrated with EAM was studied in the group of 295 patients with a wide spectrum of cardiac 
arrhythmias. Using the UniVuTM Module has significantly contributed to the reduction in the 
fluoroscopy time and dose without a prolongation in the total procedure time (median ablation 
procedure time 135 [IQR: 113; 170] minutes) (11). In AF group, using UniVuTM has reduced 
the radiation exposure by 60% of the time (p < 0.001) and 49% of the dose (p < 0.001). In the 
prospective, randomized study, 80 patients with paroxysmal AF will also have benefitted from 
the UniVuTM Module use. The implementation of the integrated fluoroscopy with 3D system 
resulted in 84% of fluoroscopy time reduction (1,75 [IQR: 1,08; 1,37] vs. 10,7 [IQR: 8,8; 
12,8), p< 0,001) and 73% of fluoroscopy dose reduction during the AF ablation [12]. Similar 
results were published in the study by Akbulak et al. [7]. In observation of 60 patients with 
paroxysmal AF both were reduced: the dose (476.5 ± 282.0 vs. 882.9 ± 550.4 cGycm2, p = 
0.001) and the radiation exposure time (7.4 ± 2.6 vs. 11.9 ± 2.1 minutes, p = 0.0006).  
What draws the attention in a closer analysis of data is the comparable efficacy of the 
procedures 6 months after the experience in both groups (75.0% vs. 81.3%, p = ns) and in the 
whole population (78.2 %). The results correlate with those published by the Akbular et al. 
after 125.7 ± 45.6 days observation with the attested 81.7 % patients free from any AF 
episodes, similarly to the Huo et al. with 5.9 ± 1.3 months observation and 76.3 % patients 
without AF(12).  
 
Conclusions 
The AF catheter ablation using an integrated model of classic fluoroscopy and 3D mapping 
system is safe and has resulted in a significant reduction of fluoroscopy time and dose. The 
same success rate after a follow-up was achieved without a prolongation of the procedure 
time and an increase in the rate of complications. This real-life population results corresponds 
with previously presented prospective studies. 
 
Study limitations 
The study we present is, a retrospective observational analysis from the single center. 
Secondly, only patients who suffered from paroxysmal AF were recruited in the present study. 
Moreover, compared group has not been homogenous. As mentioned previously patients from 
UniVuTM Module group were younger (p = 0.036). Due to retrospective nature of this study a 
limited number of parameters was a subject to our analysis with the measurements of the 
entire dose and time of fluoroscopy, without any emphasis put to the state after TSP. One 
should also remember about that additional dose of radiation exposure during pre- procedural 
CT scan, not analyzed in our study. Lastly, since this study was designed to investigate 
whether a novel non-fluoroscopic imaging system reduces the procedure and fluoroscopy 
times of catheter ablation in real-life population, we limited data only to the mid-term clinical 
outcomes, without any information on long-term outcomes. 
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Table 1. Baseline characteristics 
Table 2. Periprocedural and outcome data depends on the used 3D mapping system. 
Figure 1. Standard RAO 30 and PA position captured with integrated fluoroscopy.  
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Demographics date     
Age [years] 58 ± 10 60 ± 11 56 ± 9 0.036 
Male [%] 63.5 66.7 60.4 0.53 
Weight [kg] 79 ± 17 90 ± 14 89 ± 17 0.78 
BMI [kg/m2] 29.4 [25.7; 33.1] 29.2 [27.1; 31.6] 30.1 [25.3; 33.4] 0.73 
Hypertension [%] 71.2 72.9 70.8 0.82 
Diabetes [%] 25.0 18.8 31.3 0.16 
CHA2DS2VASc 1.0 [1.0; 3.0] 2.0 [1.0; 3.0] 1.0 [1.0; 2.0] 0.13 
HASBLED 1.0 [1.0; 1.0] 1.0 [0.0; 2.0] 1.0 [0.0; 1.0] 0.28 
Echocardiographic parameters     
LVEF [%] 55 ± 7 55 ± 5 55 ± 8 0.98 
LA diameter [mm] 42.0 ± 4.5 42.2 ± 4.6 41.0 ± 4.6 0.21 
LA diameter ≥ 40mm [%] 64.6 70.8 58.3 0.25 
LA area [cm2] 21 ± 4.8 21.6 ± 3.3 20.9 ± 5.6 0.64 
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Total procedure time [min] 144 ± 26 140 ± 27 149 ± 24 0.07 
Total fluoroscopy dose [mGy] 345.5 [221.3; 682.3] 460.0 [288.0; 785.5] 271.0 [145.0; 535.0] 0.001 
Total fluoroscopy time [min] 9.2 ± 4.4 11.6 ± 4.3 6.7 ± 2.9 <0.001 
Total RF aplications time 
[seconds] 
3092 ± 1131 3161 ± 1212 3010 ± 1037 0.54 
Efficacy and safety endopints 
Periprocedural efficacy [%] 100.0 100.0 100.0 1.0 
AF recurrence during hospital 
stay [%] 
8.3 10.4 6.3 0.16 
In-hospital complications [%] 3.1 4.2 2.1 0.14 
6-months efficacy [%] 78.2 75.0 81.3 0.31 
